Rohan Bareja
Impact in
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
- Cancer, Lipids, and Metabolism
-
- Prostate Cancer Treatment and Research
Papers in
-
- Chromatin Remodeling and Cancer 4
- Protein Degradation and Inhibitors 3
-
- Prostate Cancer Treatment and Research 12
- Co-authors
- Andrea Sboner (18 shared papers)Himisha Beltran (11 shared papers)Olivier Elemento (25 shared papers)Mark A. Rubin (8 shared papers)Vincenza Conteduca (7 shared papers)Xing Du (1 shared paper)Lewis C. Cantley (1 shared paper)Yan Ma (1 shared paper)
- Journals
- Nature Communications (4 papers)Cancer Research (4 papers)Journal of Clinical Oncology (3 papers)Cell Reports (2 papers)Radiology Artificial Intelligence (1 paper)
- Partner nations
- United StatesIsraelItaly
In The Last Decade
Rohan Bareja
41 papers receiving 1.4k citations
Rohan Bareja's Hit Papers
Peers
Comparison fields: 5 of 84
- Cancer Research 390
- Pulmonary and Respiratory Medicine 517
- Oncology 362
- Molecular Biology 824
- Genetics 72
Countries citing papers authored by Rohan Bareja
This map shows the geographic impact of Rohan Bareja's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rohan Bareja with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rohan Bareja more than expected).
Fields of papers citing papers by Rohan Bareja
This network shows the impact of papers produced by Rohan Bareja. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rohan Bareja. The network helps show where Rohan Bareja may publish in the future.
Co-authors
The 25 scholars most cited alongside Rohan Bareja, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Suppression of insulin feedback enhances the efficacy of PI3K inhibitors Hit paper breakdown → | 2018 | 481 |
| 2 | Clinical features of neuroendocrine prostate cancer Hit paper breakdown → | 2019 | 232 |
| 3 | 2019 | 116 | |
| 4 | 2019 | 69 | |
| 5 | 2018 | 64 | |
| 6 | 2017 | 55 | |
| 7 | 2021 | 50 | |
| 8 | 2017 | 47 | |
| 9 | 2020 | 46 | |
| 10 | 2020 | 40 | |
| 11 | 2020 | 31 | |
| 12 | 2018 | 31 | |
| 13 | 2018 | 29 | |
| 14 | 2023 | 19 | |
| 15 | 2020 | 19 | |
| 16 | 2020 | 13 | |
| 17 | 2016 | 11 | |
| 18 | 2020 | 11 | |
| 19 | 2022 | 10 | |
| 20 | 2021 | 9 |
About Rohan Bareja
Rohan Bareja is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research, Oncology and Radiology, Nuclear Medicine and Imaging, having authored 42 papers that have together received 1.4k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (12 papers), Cancer Genomics and Diagnostics (5 papers), Chromatin Remodeling and Cancer (4 papers), Glioma Diagnosis and Treatment (4 papers), PARP inhibition in cancer therapy (4 papers), Cancer, Hypoxia, and Metabolism (4 papers), Protein Degradation and Inhibitors (3 papers) and Optical Coherence Tomography Applications (3 papers). The work is most often cited by research in Cancer Research (390 citations), Pulmonary and Respiratory Medicine (517 citations), Oncology (362 citations), Molecular Biology (824 citations) and Genetics (72 citations). Rohan Bareja has collaborated with scholars based in United States, Israel and Italy. Frequent co-authors include Andrea Sboner, Himisha Beltran, Olivier Elemento, Mark A. Rubin, Vincenza Conteduca, Xing Du, Lewis C. Cantley, Yan Ma, Diana G. Wang and Marcus D. Goncalves. Their work appears in journals such as Nature Communications, Cancer Research, Journal of Clinical Oncology, Cell Reports and Radiology Artificial Intelligence.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.